The Pfizer vaccine will be available for sale in pharmacies in the United States starting next month, a spokesperson said Monday.
Pfizer said in a statement that the trial is “under way” and will be completed by September 2018.
The trial will include patients with severe, refractory COVID-19, who will be tested at two sites and will then receive the vaccine.
Pfiser said in the statement that Pfizer will continue to work with the Centers for Disease Control and Prevention (CDC) and other government agencies to help the company determine the best route to market.
Pfizers co-founder and chief executive officer Michael Pearson is the former director of the National Institute of Allergy and Infectious Diseases.
Pfisers co-founders Michael Pearson and David Hill are the former CEO and CFOs of Covid-19 vaccine maker Pfizer.
Pfills co-chief medical officer Andrew Weil, who was previously Pfizer CEO, is currently the CEO of Gilead Sciences.
In February, the company agreed to pay $6.2 billion to settle claims from doctors and others who said the company’s vaccines caused more than 300,000 cases of coronavirus, a condition that includes severe fever, fatigue and weakness.
Pfishers vaccines will not be available to the public.
It will be a trial to see whether the vaccine is safe and effective, the statement said.